1. Home
  2. LITB vs EVAX Comparison

LITB vs EVAX Comparison

Compare LITB & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightInTheBox Holding Co. Ltd.

LITB

LightInTheBox Holding Co. Ltd.

HOLD

Current Price

$2.06

Market Cap

37.7M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.49

Market Cap

31.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LITB
EVAX
Founded
2007
2008
Country
Singapore
Denmark
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.7M
31.9M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
LITB
EVAX
Price
$2.06
$4.49
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$11.67
AVG Volume (30 Days)
9.3K
31.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.50
N/A
Revenue Next Year
$11.59
$328.20
P/E Ratio
$10.96
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$1.42
52 Week High
$4.17
$12.15

Technical Indicators

Market Signals
Indicator
LITB
EVAX
Relative Strength Index (RSI) 47.70 62.84
Support Level $1.88 $2.64
Resistance Level $2.25 $4.62
Average True Range (ATR) 0.13 0.33
MACD -0.01 0.01
Stochastic Oscillator 36.36 70.00

Price Performance

Historical Comparison
LITB
EVAX

About LITB LightInTheBox Holding Co. Ltd.

LightInTheBox Holding Co Ltd is a e-commerce company, providing a diverse range of affordable lifestyle products directly to consumers. Its brands include Ador, a women's fashion brand targeting women aged 35-55; the second is a golf apparel brand focusing on female golfers aged 35 and above; the third is a women's light party dress brand for the age group of 30 and above. It offers customers products through websites and mobile applications. The company operates and reviews its performance in two segments: Product sales which consisted of online retailing of consumer products and sales to third-party sellers, and Services which consisted of the provision of logistic services to companies and individual customers.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: